Connection

UDDALAK BHARADWAJ to Recombinant Fusion Proteins

This is a "connection" page, showing publications UDDALAK BHARADWAJ has written about Recombinant Fusion Proteins.
  1. Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Mol Cancer Ther. 2008 Feb; 7(2):286-96.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.